Insider Buying: Nexalin Technology, Inc. (NASDAQ:NXL) VP Buys $13,200.00 in Stock

Nexalin Technology, Inc. (NASDAQ:NXLGet Free Report) VP Carolyn Hamby Shelton bought 6,000 shares of the stock in a transaction that occurred on Wednesday, March 12th. The stock was bought at an average cost of $2.20 per share, for a total transaction of $13,200.00. Following the completion of the purchase, the vice president now directly owns 30,000 shares of the company’s stock, valued at $66,000. This represents a 25.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Nexalin Technology Stock Performance

Shares of Nexalin Technology stock opened at $2.15 on Friday. The stock has a market capitalization of $28.60 million, a price-to-earnings ratio of -3.36 and a beta of 4.33. The company has a fifty day moving average of $2.85 and a 200-day moving average of $2.48. Nexalin Technology, Inc. has a 52-week low of $0.35 and a 52-week high of $4.49.

Nexalin Technology (NASDAQ:NXLGet Free Report) last released its quarterly earnings data on Friday, March 14th. The company reported ($0.28) earnings per share for the quarter. Nexalin Technology had a negative net margin of 3,407.98% and a negative return on equity of 187.59%. The company had revenue of $0.03 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Maxim Group reissued a “hold” rating on shares of Nexalin Technology in a report on Thursday, December 5th.

View Our Latest Stock Report on NXL

Institutional Investors Weigh In On Nexalin Technology

A number of large investors have recently modified their holdings of NXL. Kingsview Wealth Management LLC purchased a new position in Nexalin Technology during the 4th quarter valued at about $28,000. Jane Street Group LLC bought a new position in shares of Nexalin Technology during the fourth quarter valued at approximately $28,000. Northern Trust Corp bought a new stake in shares of Nexalin Technology in the 4th quarter worth approximately $36,000. XTX Topco Ltd purchased a new stake in shares of Nexalin Technology in the 4th quarter worth approximately $46,000. Finally, Drive Wealth Management LLC bought a new position in Nexalin Technology during the 4th quarter valued at approximately $55,000. Institutional investors own 0.65% of the company’s stock.

About Nexalin Technology

(Get Free Report)

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.

Featured Stories

Insider Buying and Selling by Quarter for Nexalin Technology (NASDAQ:NXL)

Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.